Tech Company Financing Transactions

Exosome Diagnostics Funding Round

Arcus Ventures, Qiagen and CD Ventures invested in a $27 million Series B funding round for Exosome Diagnostics. The round was announced on 3/11/2014.

Transaction Overview

Company Name
Exosome Diagnostics
Announced On
3/11/2014
Transaction Type
Venture Equity
Amount
$27,000,000
Round
Series B
Investors

Arcus Ventures (Lead Investor) (Steven Soignet)

Qiagen (Lead Investor)

CD Ventures

Forbion Capital Partners (Geert-Jan Mulder)

Monashees Capital

NGN Capital (Peter Johann)

Tiger Global Management

Proceeds Purpose
Proceeds will be used to advance development of the Company's proprietary platform technology and commercial programs for non-invasive, fluid-based molecular diagnostics in oncology, neurodegenerative diseases and other clinical areas.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
266 Second Ave. 200
Waltham, MA 02451
USA
Phone
(617) 588-0500
Website
www.exosomedx.com
Email Address
[email protected]
Overview
Developing and commercializing personalized biofluid-based diagnostic tests for use in companion diagnostic applications and real-time disease monitoring.
Profile
Exosome Diagnostics LinkedIn Company Profile
Social Media
Exosome Diagnostics Company Twitter Account
Company News
Exosome Diagnostics News
Facebook
Exosome Diagnostics on Facebook
YouTube
Exosome Diagnostics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
John Boyce
  John Boyce LinkedIn Profile  John Boyce Twitter Account  John Boyce News  John Boyce on Facebook
Chief Financial Officer
William Kelly
  William Kelly LinkedIn Profile  William Kelly Twitter Account  William Kelly News  William Kelly on Facebook
Chief Medical Officer
Vincent O'Neill
  Vincent O'Neill LinkedIn Profile  Vincent O'Neill Twitter Account  Vincent O'Neill News  Vincent O'Neill on Facebook
Chief Operating Officer
Thomas McLain
  Thomas McLain LinkedIn Profile  Thomas McLain Twitter Account  Thomas McLain News  Thomas McLain on Facebook
Chief Scientific Officer
Johan Skog
  Johan Skog LinkedIn Profile  Johan Skog Twitter Account  Johan Skog News  Johan Skog on Facebook
VP - Product Management
Mikkel Noerholm
  Mikkel Noerholm LinkedIn Profile  Mikkel Noerholm Twitter Account  Mikkel Noerholm News  Mikkel Noerholm on Facebook
VP - Regulatory Affairs
Raaj Venkatesan
  Raaj Venkatesan LinkedIn Profile  Raaj Venkatesan Twitter Account  Raaj Venkatesan News  Raaj Venkatesan on Facebook

 

 

Browse more venture capital transactions:

Prev: 3/11/2014: Synata venture capital transaction
Next: 3/11/2014: GroundMetrics venture capital transaction

 

Share this article

 

Where The Data Comes From

We record every notable VC transaction. All VC database entries on this site are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.